BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT03277729-completion@plaintrial.com
DTSTAMP:20261027T211135Z
DTSTART;VALUE=DATE:203903
SUMMARY:A Phase I/II Study to Evaluate the Safety of Cellular Immunotherapy
  Using Autologous T Cells Engineered to Express a CD20-Specific Chimeric A
 ntigen Receptor for Patients With Relapsed or Refractory B Cell Non-Hodgki
 n Lymphomas — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT03277729
URL:https://plaintrial.com/trial/NCT03277729
END:VEVENT
END:VCALENDAR